These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20409682)

  • 21. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.
    Wilson AM; Kimura E; Harada RK; Nair N; Narasimhan B; Meng XY; Zhang F; Beck KR; Olin JW; Fung ET; Cooke JP
    Circulation; 2007 Sep; 116(12):1396-403. PubMed ID: 17724262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type D personality and mortality in peripheral arterial disease: a pilot study.
    Aquarius AE; Smolderen KG; Hamming JF; De Vries J; Vriens PW; Denollet J
    Arch Surg; 2009 Aug; 144(8):728-33. PubMed ID: 19687376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index.
    Brevetti G; Silvestro A; Schiano V; Chiariello M
    Circulation; 2003 Oct; 108(17):2093-8. PubMed ID: 14530195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
    van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
    Rask O; Hanséus K; Ljung R; Strandberg K; Berntorp E
    Cardiol Young; 2009 Apr; 19(2):152-8. PubMed ID: 19195416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral arterial disease in patients with stages IV and V chronic renal failure.
    Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A
    Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset of peripheral arterial disease: role of endothelin in endothelial dysfunction.
    de Haro Miralles J; Gónzalez AF; Varela Casariego C; García FA
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):760-5. PubMed ID: 20154344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive value of diabetes and peripheral arterial disease in the risk stratification of patients admitted after an acute coronary syndrome: a subanalysis of the PAMISCA Study.
    Pastor-Perez FJ; Soria-Arcos F; Morillas-Blasco P; Quiles-Granado J; Mazón-Ramos P; Guindo-Soldevila J; Rodriguez-Padial L; González-Maqueda I; González-Juanatey JR; Bertomeu-Martínez V
    Int J Clin Pract; 2009 Sep; 63(9):1314-9. PubMed ID: 19691614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study.
    O'Hare AM; Newman AB; Katz R; Fried LF; Stehman-Breen CO; Seliger SL; Siscovick DS; Shlipak MG
    Arch Intern Med; 2005 Dec 12-26; 165(22):2666-70. PubMed ID: 16344426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb.
    Brevetti G; Colao A; Schiano V; Pivonello R; Laurenzano E; Di Somma C; Lombardi G; Chiariello M
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):894-900. PubMed ID: 18410545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Jeremias A; Gruberg L; Patel J; Connors G; Brown DL
    Am J Cardiol; 2010 May; 105(9):1268-71. PubMed ID: 20403477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of proteolysis, fibrinolysis, and coagulation in relation to size and growth rate of abdominal aortic aneurysms.
    Flondell-Sité D; Lindblad B; Kölbel T; Gottsäter A
    Vasc Endovascular Surg; 2010 May; 44(4):262-8. PubMed ID: 20356864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients.
    Martin M; Gottsäter A; Nilsson PM; Mollnes TE; Lindblad B; Blom AM
    J Vasc Surg; 2009 Jul; 50(1):100-6. PubMed ID: 19563958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.
    Tchaikovski SN; Thomassen MC; Costa SD; Peeters LL; Rosing J
    Thromb Haemost; 2011 Nov; 106(5):914-21. PubMed ID: 21979881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.